Roberto Padrini

Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans

Harumi Takahashi, G. Wilkinson, Edith A. Nutescu et al. · Pharmacogenetics and Genomics · 2006 · 374 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor

Lisa Gallinaro, Maria Grazia Cattini, Maryta Sztukowska et al. · Blood · 2008 · 301 citations · Full text

Medicine, Hematology, Immunology +12

Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers

Pietro Palatini, L. Tedeschi, Roberto Padrini et al. · European Journal of Clinical Pharmacology · 1993 · 217 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +7

Reduced von Willebrand factor survival in type Vicenza von Willebrand disease

Alessandra Casonato, Elena Pontara, Francesca Sartorello et al. · Blood · 2002 · 165 citations

Medicine, Immunology, Pathobiology +10

Diagnostic Value of Plasma Cystatin C as a Glomerular Filtration Marker in Decompensated Liver Cirrhosis

Rocco Orlando, Michele Mussap, Mario Plebani et al. · Clinical Chemistry · 2002 · 158 citations · Full text

Medicine, Nephrology, Renal Pathology +16